ReviewMaterials today. Bio2022
Smartphone-based mobile biosensors for the point-of-care testing of human metabolites.
Review in Materials today. Bio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The intelligent neonatal healthcare: a systematic review of machine learning architectures integrating the internet of medical things and blockchain.Frontiers in artificial intelligence · 2026Pooled it
- Biophotonics point-of-care diagnostics in low-resource settings: a South African perspective.Journal of biomedical optics · 2026Review
- Quantification of the Kynurenine Biomarker in Saliva Using Smatphone-Based Fluorescence Digital Imaging.ACS omega · 2026Article
- Potential biomarkers and their recent applications ofr point-of-care biosensors for the diagnosis of malaria.Mikrochimica acta · 2026Review
- Biosensing technologies for foodborne pathogen detection and healthcare: principles, emerging materials, and intelligent platforms.Mikrochimica acta · 2026Review
- Luminescence-Based Strategies for Detecting β-Lactamase Activity: A Review of the Last Decade.Life (Basel, Switzerland) · 2026Review
- Advances in rapid detection technologies for zoonotic diseases: a one health-oriented review.Frontiers in cellular and infection microbiology · 2026Review
- Paper-Based Device for the Colorimetric Determination of Glucose in Whole-Blood Samples Using a Smartphone.Bioengineering (Basel, Switzerland) · 2025Article
- Miniaturization of a colorimetric cellulase activity assay on a microfluidic sensor platform.RSC advances · 2025Article
- Activation of enzymatic catalysis via nucleic acid hybridization affords synergistic coupling of specificity, potency, and signal amplification.Nature communications · 2025Article
- Leveraging Deep Learning to Address Diagnostic Challenges with Insufficient Image Data.ACS sensors · 2025Article
- 4D-printed microdevices for spatiotemporal detection of ctDNA and miRNA in pancreatic cancer: an in-depth review.Medical oncology (Northwood, London, England) · 2025Review
- Smartphone-Integrated Electrochemical Devices for Contaminant Monitoring in Agriculture and Food: A Review.Biosensors · 2025Review
- A portable smartphone-based electrochemical sensing platform for rapid and sensitive detection of creatinine in blood serum.RSC advances · 2025Article
- Development of Time-Resolved Luminescence Measurement Instruments for Biosensing and Bioimaging - An Overview.Measurement : journal of the International Measurement Confederation · 2025Article
- Recent Advances in Vehicle Driver Health Monitoring Systems.Sensors (Basel, Switzerland) · 2025Review
- Patient-centred newer testing methods for major cardiac disorders.Indian journal of thoracic and cardiovascular surgery · 2025Review
- Conductive hydrogels: intelligent dressings for monitoring and healing chronic wounds.Regenerative biomaterials · 2025Review
- MOF-based spectrophotometric sensors for cholesterol detection: current trends and challenges.RSC advances · 2024Review
- Recent advances in dual response molecular probes for biothiols.Smart molecules : open access · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid, accurate, portable and quantitative profiling of metabolic biomarkers is of great importance for disease diagnosis and prognosis. The recent development in the optical and electric biosensors based on the smartphone is promising for profiling of metabolites with advantages of rapid, reliability, accuracy, low-cost and multi-analytes analysis capability. In this review, we introduced the optical biosensing platforms including colorimetric, fluorescent and chemiluminescent sensing, and electrochemical biosensing platforms including wired and wireless communication. Challenges and future perspectives desired for reliable, accurate, cost-effective, and multi-functions smartphone-based biosensing systems were also discussed. We envision that such smartphone-based biosensing platforms will allow daily and comprehensive metabolites monitoring in the future, thus unlocking the potential to transform clinical diagnostics into non-clinical self-testing. We also believed that this progress report will encourage future research to develop advanced, integrated and multi-functional smartphone-based Point-of-Care testing (POCT) biosensors for the monitoring and diagnosis as well as personalized treatments of a spectrum of metabolic-disorder related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.